Press Releases Year None202120202019201820172016 Jul 13, 2021 Imara Announces Pricing of Public Offering Jul 13, 2021 Imara Announces Launch of Proposed Public Offering Jun 30, 2021 Imara Announces Appointment of Laura A. Williams, M.D., MPH to Board of Directors Jun 17, 2021 Imara Announces Recipients of the Second Annual Real Impact Grants Program to Support People Affected by Rare Genetic Blood Disorders Jun 11, 2021 Imara Presents Clinical Data on IMR-687 in Sickle Cell Disease at the European Hematology Association (EHA) Annual Congress Jun 04, 2021 Imara to Present Clinical Data on IMR-687 in Sickle Cell Disease at the European Hematology Association (EHA) Annual Congress May 11, 2021 Imara Reports First Quarter 2021 Financial Results and Business Highlights May 04, 2021 Imara to Webcast Conference Call of First Quarter 2021 Financial Results and Business Highlights Mar 29, 2021 Imara Opens Applications for the Second-Annual ‘Real Impact’ Community Support Program to Address Unmet Needs Affecting People with Rare Genetic Blood Disorders Mar 17, 2021 Imara Announces Opening of Higher Dose Arms in Global Phase 2b Clinical Trials of IMR-687 for Sickle Cell Disease and Beta-Thalassemia Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 15
Press Releases Year None202120202019201820172016 Jul 13, 2021 Imara Announces Pricing of Public Offering Jul 13, 2021 Imara Announces Launch of Proposed Public Offering Jun 30, 2021 Imara Announces Appointment of Laura A. Williams, M.D., MPH to Board of Directors Jun 17, 2021 Imara Announces Recipients of the Second Annual Real Impact Grants Program to Support People Affected by Rare Genetic Blood Disorders Jun 11, 2021 Imara Presents Clinical Data on IMR-687 in Sickle Cell Disease at the European Hematology Association (EHA) Annual Congress Jun 04, 2021 Imara to Present Clinical Data on IMR-687 in Sickle Cell Disease at the European Hematology Association (EHA) Annual Congress May 11, 2021 Imara Reports First Quarter 2021 Financial Results and Business Highlights May 04, 2021 Imara to Webcast Conference Call of First Quarter 2021 Financial Results and Business Highlights Mar 29, 2021 Imara Opens Applications for the Second-Annual ‘Real Impact’ Community Support Program to Address Unmet Needs Affecting People with Rare Genetic Blood Disorders Mar 17, 2021 Imara Announces Opening of Higher Dose Arms in Global Phase 2b Clinical Trials of IMR-687 for Sickle Cell Disease and Beta-Thalassemia Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 15
Jun 17, 2021 Imara Announces Recipients of the Second Annual Real Impact Grants Program to Support People Affected by Rare Genetic Blood Disorders
Jun 11, 2021 Imara Presents Clinical Data on IMR-687 in Sickle Cell Disease at the European Hematology Association (EHA) Annual Congress
Jun 04, 2021 Imara to Present Clinical Data on IMR-687 in Sickle Cell Disease at the European Hematology Association (EHA) Annual Congress
May 04, 2021 Imara to Webcast Conference Call of First Quarter 2021 Financial Results and Business Highlights
Mar 29, 2021 Imara Opens Applications for the Second-Annual ‘Real Impact’ Community Support Program to Address Unmet Needs Affecting People with Rare Genetic Blood Disorders
Mar 17, 2021 Imara Announces Opening of Higher Dose Arms in Global Phase 2b Clinical Trials of IMR-687 for Sickle Cell Disease and Beta-Thalassemia
